22 January 2019
By Dr Wendy Winnall - PCFA Research Team
Some prostate cancers are more aggressive than others. They grow quickly, spread and become resistant to drugs. Developing better treatments for aggressive prostate cancers is a major research priority. Results have been published from a new study indicating an alternative to hormone signalling may be driving the growth of some aggressive prostate cancers. This study has uncovered a new way to target prostate cancer, aside from drugs that suppress testosterone.
To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.
